Handling and Processing of Blood Specimens from Patients with COVID-19 for Safe Studies on Cell Phenotype and Cytokine Storm

Cytometry A. 2020 Jul;97(7):668-673. doi: 10.1002/cyto.a.24009. Epub 2020 Apr 10.

Abstract

The pandemic caused by severe acute respiratory syndrome coronavirus 2 heavily involves all those working in a laboratory. Samples from known infected patients or donors who are considered healthy can arrive, and a colleague might be asymptomatic but able to transmit the virus. Working in a clinical laboratory is posing several safety challenges. Few years ago, International Society for Advancement of Cytometry published guidelines to safely analyze and sort human samples that were revised in these days. We describe the procedures that we have been following since the first patient appeared in Italy, which have only slightly modified our standard one, being all human samples associated with risks. © 2020 International Society for Advancement of Cytometry.

Keywords: Covid-19; SARS-CoV-2; biosafety; coronavirus; cytokines; cytometry.

MeSH terms

  • Betacoronavirus*
  • COVID-19
  • Coronavirus Infections / blood*
  • Cytokine Release Syndrome / blood
  • Flow Cytometry / methods
  • Humans
  • Italy
  • Masks
  • Medical Laboratory Personnel*
  • Occupational Exposure / prevention & control
  • Occupational Health*
  • Pandemics
  • Pneumonia, Viral / blood*
  • Protective Clothing
  • SARS-CoV-2
  • Specimen Handling / methods*